A fundamental element in the advancement of scientific knowledge is the publication of research in a peer-reviewed journal, which supports and reflects the scientific method. Such publication reflects the quality of the work carried out by authors and their affiliated institutions. Therefore, all parties involved in the publication process, including editors, peer reviewers, publishers, and scientific societies associated with journals, are expected to fulfil their ethical responsibilities.
Le Infezioni in Medicina adheres to the ethical principles established by the World Medical Association (WMA) Declaration of Helsinki (2024), concerning medical research involving human participants, including research using identifiable human material or data.
Particular attention is given to the ethical responsibilities of authors, editors, and publishers in the reporting and publication of scientific research, as established by the Declaration of Helsinki.
Authors are responsible for the completeness and accuracy of their reports and should follow recognized guidelines for ethical reporting. Research findings, whether positive, negative, or inconclusive, must be published or otherwise made publicly available. Sources of funding, institutional affiliations, and conflicts of interest must be disclosed. Reports of research that does not comply with the principles of the Declaration should not be accepted for publication.
Clinical trials must be prospectively registered in accordance with the requirements set out in the Clinical Trial Registration section below. Research involving identifiable human biological materials or data must comply with applicable informed consent and ethical requirements.
Further details are provided in the sections on research involving human participants, informed consent, and clinical trial registration below.
Mission of the Publisher
The above requirements form the basis of these guidelines, which recognize the role of the publisher in supporting the efforts of journal editors and the often unrecognized work of peer reviewers in preserving the integrity of the scholarly record.
The publisher is responsible not only for supporting scholarly communication but also for upholding best practices in scholarly publishing.
By adopting appropriate policies and procedures and providing clear guidelines to editors, authors, and reviewers, the publisher supports them in fulfilling their ethical responsibilities.
The publisher is committed to ensuring that editorial decisions remain independent of advertising, reprint sales, and other commercial sources of revenue.
The publisher supports education and guidance on publication ethics for researchers, particularly those at an early stage of their scientific careers.
All research articles published in Le Infezioni in Medicina are subject to rigorous ethical standards. The journal endorses the principles and Core Practices of the Committee on Publication Ethics (COPE).
The journal follows the recommendations of the International Committee of Medical Journal Editors (ICMJE).
The Editorial Board is responsible for the journal's peer-review process. Authors submitting manuscripts to Le Infezioni in Medicina must follow the journal's Manuscript Preparation guidelines and the current ICMJE Recommendations.
Duties of Editors
The Editor-in-Chief is responsible for decisions concerning the publication of submitted manuscripts, even when working in collaboration with other editors or members of the Editorial Board. Such decisions play an important role in determining which scientific contributions are made available to researchers and readers.
To ensure a fair, unbiased, and timely peer-review process, the editor should arrange for manuscripts to be evaluated by at least two external reviewers. Reviewers must be selected on the basis of their expertise, and appropriate measures must be taken to prevent fraudulent peer review. Potential conflicts of interest and inappropriate requests for self-citation must be carefully assessed to avoid bias.
Manuscripts must be evaluated without discrimination based on the authors' race, gender, sexual orientation, religious beliefs, ethnic origin, citizenship, or political opinions. Editors should encourage transparency and accurate reporting and clearly communicate their expectations to reviewers and authors. References to articles published in the journal, including those authored by editors, must be requested or recommended only for legitimate scientific reasons. Editors must not promote citations or references to products or services in which they have a personal interest.
All materials submitted to the journal and all communications with reviewers must be treated as confidential and must not be disclosed except as agreed with the relevant authors and reviewers or as required by the journal's editorial procedures.
If an editor considers it necessary to investigate suspected research misconduct, relevant information may be shared with other editors, subject to appropriate confidentiality safeguards. Reviewers' identities must be protected unless an open peer-review system is in place or disclosure has been agreed upon. Editors must not use unpublished material contained in a submitted manuscript without the author's explicit written consent.
Editors must not disclose or use for personal advantage any confidential information or ideas obtained through the peer-review process.
Editors must disclose any actual or potential conflicts of interest to the publisher and promptly report any changes. They must not participate in editorial decisions concerning manuscripts submitted by themselves, family members, close colleagues, or others with whom they have relationships that could compromise impartiality. Such submissions must be managed independently through the journal's established editorial procedures, with appropriate disclosure of relevant conflicts in the published article.
The editor must cooperate with the publisher to safeguard the integrity of the published scientific record.
When research or publication misconduct, including plagiarism, is suspected, editors must take appropriate steps to assess the matter, which may involve contacting the authors, their institutions, or relevant research organizations. Editors must cooperate with the publisher to ensure the prompt publication of any necessary corrections, expressions of concern, or retractions, in accordance with recognized publication ethics guidelines.
Duties of Reviewers
Peer review is an essential component of scholarly communication and is closely connected to the scientific method. It contributes to editorial decisions and helps authors improve their manuscripts. Reviewers who consider themselves insufficiently qualified to evaluate a manuscript or unable to complete the review within the requested timeframe should promptly inform the editor and decline the invitation.
All manuscripts received for review must be treated as confidential documents. Reviewers must not disclose information about submitted manuscripts or contact the authors concerning the review without prior authorization from the editor. Unpublished material contained in a submitted manuscript must not be used in a reviewer's own research. Information or ideas obtained through peer review must remain confidential and must not be used for personal advantage.
Reviewers should identify relevant published work that has not been appropriately cited and inform the editor of any relevant similarity or overlap between the submitted manuscript and previously published material.
Reviews must be objective, and personal criticism of authors must be avoided. Reviewers' comments should be clearly supported by scientific arguments. Before accepting a review invitation, reviewers must inform the editor of any potential conflicts of interest arising from competitive or collaborative relationships with the authors, companies, or institutions involved in the research. References to a reviewer's own work should be recommended only when scientifically justified and not for the purpose of increasing its visibility.
Duties of Authors
Reports of original research must provide an accurate account of the work performed, supported by reliable data, sufficient methodological detail, and appropriate references. Failure to meet these standards may constitute unethical conduct. The same principles of accuracy apply to review articles, other scholarly articles, and editorial opinions.
Authors should make their research data publicly accessible, where ethically and legally permissible, and retain the original data for an appropriate period in accordance with applicable institutional, legal, and ethical requirements.
Authors must submit original work and appropriately acknowledge and cite the words, ideas, and findings of others. Material reproduced from other sources must be properly quoted or referenced, and any necessary permissions must be obtained. Information obtained through private communications must not be used without authorization from the source. Plagiarism in any form is unacceptable and constitutes unethical conduct.
Authors must not publish substantially the same research in more than one journal, as duplicate or redundant publication constitutes unacceptable publication practice. Previous dissemination in the form of an abstract, conference presentation, academic thesis, or electronic preprint should be disclosed and assessed in accordance with the journal's editorial policies.
Certain types of articles, such as clinical guidelines or translations, may be considered for secondary publication when the authors and editors have reached an appropriate agreement. The secondary publication must accurately reflect the data and interpretation of the primary publication, which must be clearly acknowledged and cited.
Authors must not use information obtained through confidential services without appropriate written permission.
All individuals who have made substantial contributions to the reported study and qualify for authorship should be listed as authors. Individuals who have contributed to specific aspects of the work, such as language editing or medical writing, but do not qualify for authorship should be acknowledged in the Acknowledgements section.
The corresponding author must ensure that all coauthors are appropriately included and have reviewed and approved the final version of the manuscript. Before submission, authors should carefully verify the list and order of authors. Requests for additions, deletions, or rearrangements of authors after submission will be considered by the editor only in exceptional circumstances.
All authors are collectively responsible for the work and must cooperate in investigating and resolving questions concerning its accuracy or integrity.
Authors must identify and appropriately describe any potential hazards associated with chemicals, procedures, equipment, or research involving human participants or animals.
Authors must include a statement confirming that the research was conducted in accordance with applicable laws and ethical requirements and that the necessary informed consent and ethical approvals were obtained, where required.
Research involving human participants must be conducted in accordance with the World Medical Association Declaration of Helsinki (2024) and applicable ethical and legal requirements.
Research involving animals must comply with applicable animal welfare regulations and must be reported in accordance with the ARRIVE Guidelines 2.0, where applicable. Depending on the jurisdiction and the circumstances of the research, relevant requirements may include the UK Animals (Scientific Procedures) Act 1986, EU Directive 2010/63/EU, the US Public Health Service Policy on Humane Care and Use of Laboratory Animals, and the US Animal Welfare Act.
Authors must obtain and retain the necessary consents, permissions, and authorizations for the publication of identifiable patient case details, personal information, or images in a manuscript. Upon request, authors must provide appropriate confirmation or supporting documentation to Edizioni Internazionali S.r.l., Divisione EDIMES Edizioni Medico-Scientifiche, Via Riviera 39, 27100 Pavia, Italy, in accordance with the journal's approved procedures and applicable privacy and data protection requirements.
In their manuscripts, authors must disclose any financial or non-financial relationships or activities that could reasonably be perceived as influencing their research or its interpretation.
All sources of financial support must be disclosed, together with the role, if any, of sponsors or funding organizations in study design, data collection, analysis, interpretation, manuscript preparation, and the decision to submit the manuscript for publication.
Potential conflicts of interest may include employment, consultancy agreements, stock ownership, honoraria, patent applications, research grants, and other sources of financial or professional benefit.
If authors identify errors or inaccuracies in their published work, they must promptly notify the editor or publisher and cooperate in correcting the publication. Authors must also cooperate when an error is brought to the editor's attention by a third party.
The editor and publisher will be responsible for arranging the publication of an appropriate correction (Errata corrige) in the next issue of the journal. Where necessary, other measures, including an expression of concern or retraction, may be taken in accordance with recognized publication ethics guidelines.
Authors may adjust images only to improve clarity, without removing, introducing, obscuring, or altering features or information in a way that could misrepresent the original data. Inappropriate image manipulation constitutes a breach of publication ethics.
Detailed ethical requirements concerning research involving human participants, vulnerable populations, informed consent, clinical trial registration, and animal research are provided in the following sections of this policy.
Authors should also consult the journal's Manuscript Preparation guidelines for the corresponding manuscript submission requirements.
For further guidance, authors should consult the current Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE).
Research Ethics Policies
1. Ethical Requirements for Research Involving Human Participants
Research involving human participants, identifiable human biological material, or identifiable personal health data must be conducted in accordance with applicable ethical and legal requirements and the principles of the World Medical Association Declaration of Helsinki (2024) and the International Committee of Medical Journal Editors (ICMJE) recommendations on the protection of research participants.
Where required, research must be approved by an appropriately constituted independent research ethics committee or institutional review board before the study begins.
In accordance with the World Medical Association Declaration of Helsinki (2024), medical research involving human participants must be registered in a publicly accessible database before recruitment of the first participant. Specific requirements for clinical trials are provided in the Clinical Trial Registration section below.
Manuscripts reporting research involving human participants must include an ethics statement identifying the approving committee or institutional review board, the approval number or reference where applicable, and confirmation that the study complied with relevant ethical requirements. Authors must also describe how informed consent was obtained or explain the grounds for any applicable exception.
Where ethics approval was not required, or where an exemption or waiver was granted, authors must explain the circumstances and identify the relevant legal, institutional, or ethics committee determination, as applicable.
The Editorial Office may request supporting documentation relating to ethics approval, exemptions, waivers, or informed consent, subject to applicable privacy and data protection requirements.
2. Research Involving Vulnerable Populations
Le Infezioni in Medicina recognizes the need for specific safeguards for individuals, groups, and communities who may be particularly vulnerable in medical research, consistent with the ethical oversight principles outlined in the Committee on Publication Ethics (COPE) Core Practices, including Ethical Oversight (Core Practice 6). Vulnerability may arise from age, illness, impaired decision-making capacity, dependency, social or economic circumstances, or other factors affecting the ability to make a free and informed decision.
The inclusion of vulnerable participants must be scientifically and ethically justified, responsive to their health needs or priorities, and accompanied by appropriate protections for their rights, dignity, safety, and well-being. Such participants should be included only when the research cannot be carried out in a less vulnerable population, or when their exclusion would perpetuate or exacerbate health disparities, and when they stand to benefit from the resulting knowledge, practices, or interventions.
Children and Minors
Research involving children or minors must comply with applicable ethical and legal requirements. Consent from a parent or legally authorized representative must be obtained where required. When a child who cannot provide valid informed consent is capable of expressing assent to participation in research, age-appropriate assent must be sought in addition to consent from the parent or legally authorized representative, and documented in accordance with applicable requirements. The child's dissent should be respected, in accordance with applicable ethical and legal requirements.
Adults with Impaired Decision-Making Capacity
Where an adult cannot provide valid informed consent, consent must be sought from a legally authorized representative in accordance with applicable law and ethical requirements. The participant’s previously expressed values, wishes, and preferences must be considered, and any ability to assent or dissent must be respected.
Such participants may be included only when the study offers a prospect of personal benefit or involves no more than minimal risk and minimal burden, in accordance with the relevant ethical standards.
Unconscious or Critically Ill Patients
Research involving unconscious or critically ill patients who cannot consent must be justified by the specific characteristics of the study population and must comply with applicable law and an approved research protocol.
Consent from a legally authorized representative must be sought whenever possible. If no representative is available and the research cannot be delayed, enrolment without prior consent may occur only where permitted by law, where the reasons are specified in the protocol, and where the research ethics committee has approved the procedure. Consent for continued participation must be sought as soon as possible from the participant if capacity is regained, or otherwise from the legally authorized representative.
Deceased Patients
The use or publication of identifiable information, images, or biological material relating to deceased patients must comply with applicable laws, institutional policies, and confidentiality requirements. Permission from a legally authorized representative or next of kin must be obtained where required.
Additional Safeguards
Authors must explain in the manuscript why the inclusion of vulnerable participants was ethically justified and describe the safeguards adopted to minimize risks, protect confidentiality, and ensure appropriate consent procedures. The Editorial Office may request additional documentation, subject to applicable privacy requirements.
3. Informed Consent and Protection of Patient Privacy
Free and informed consent must be obtained from research participants whenever required by applicable ethical and legal standards, including the principles of the World Medical Association Declaration of Helsinki (2024). Consent must be voluntary and based on clear information about the research purpose, procedures, potential risks and benefits, privacy safeguards, and the right to refuse or withdraw without penalty.
Where an individual cannot provide valid consent, authorization must be sought from a legally authorized representative, as required by applicable law and ethical standards. Any permitted exception or waiver must be justified and supported by the appropriate ethics committee determination or other legally valid authorization.
Authors must protect patient privacy and confidentiality. Names, initials, hospital identification numbers, and other unnecessary identifying details must not be included in manuscripts or illustrations.
Consent to participate in research and consent to publish identifiable patient information are distinct requirements. Where clinical details, photographs, or other material could identify a patient, appropriate written consent for publication must be obtained, unless a specific exception is permitted by applicable law and ethical requirements. When written consent for publication is required, the patient or legally authorized representative must be shown the material intended for publication, including the relevant manuscript content.
Authors are responsible for obtaining and retaining the relevant consents, permissions, and authorizations. Confirmation or supporting documentation must be made available when properly requested under the journal's approved editorial procedures and applicable data protection requirements.
4. Clinical Trial Registration
Le Infezioni in Medicina requires clinical trials submitted for publication to be prospectively registered in a publicly accessible clinical trial registry that meets internationally accepted standards, in accordance with the recommendations of the International Committee of Medical Journal Editors (ICMJE).
For the purposes of this policy, a clinical trial is a research study that prospectively assigns individuals or groups of individuals to a health-related intervention to evaluate its effects on health outcomes, with or without a concurrent comparison or control group.
Registration must take place at or before the time of first participant consent for enrolment.
Acceptable registries include:
- ClinicalTrials.gov
- Primary Registries of the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP)
The WHO ICTRP itself is not a registry in which investigators can register a trial directly.
Manuscripts reporting clinical trials must include:
- The name of the trial registry.
- The registration number.
- The date of registration.
- Confirmation of whether registration was prospective or retrospective.
Registration information must be clearly reported in the manuscript.
Retrospectively registered trials must be explicitly identified as such. Authors must provide an explanation of the circumstances of late registration. The Editorial Board will assess the matter in accordance with the journal's editorial policy and the applicable ICMJE recommendations. Retrospective registration does not automatically satisfy the prospective registration requirement.
Any exception to the prospective registration requirement must be rare and appropriately justified. If an exception is granted, the publication must disclose when and why the trial was registered late, and the journal must explain why the exception was allowed.
Manuscripts reporting the results of clinical trials must include a data-sharing statement in accordance with the applicable ICMJE recommendations. Authors must also provide relevant protocol information where required.
5. Research Involving Animals
Studies involving animals must comply with the institutional, national, and international requirements applicable in the jurisdiction where the research was conducted, including relevant provisions on animal welfare and the ethical use of animals in scientific research.
Authors must confirm that appropriate approval or authorization was obtained from the relevant animal ethics committee or competent authority when required.
Manuscripts must describe the measures adopted to minimize pain, suffering, and distress and ensure appropriate care throughout the study.
Animal experiments should follow the principles of Replacement, Reduction, and Refinement (the 3Rs).
Animal research must be reported in accordance with the ARRIVE Guidelines 2.0, where applicable.
Authors are responsible for complying with the regulations applicable in the country or jurisdiction where the research was conducted.